Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Selection for growth & income: Sanofi-Aventis (SNY:42.63)

Article Abstract:

The Sanofi-Aventis stock is expected to give its investors good dividends in 2010-2012, provided the company markets more vaccines. Only 8% of Sanofi-Aventis' sales in 2006 came from vaccines, but more income can be expected from this sector. Some of Sanofi-Aventis' products, such as Accomplia, and the formation of the company are also discussed.

Author: Romaine, Sigourney B.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2007
Sales, profits & dividends, Product information, Company sales and earnings, Company earnings/profit, Company overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Sanofi-Aventis

Article Abstract:

The price appreciation potential of the shares of Sanofi-Aventis for the years 2010-2012 is discussed. The French company offers pharmaceuticals for a variety of therapeutic areas, including cardiovascular, thrombosis and metabolic disorders, and 20 vaccines.

Author: Romaine, Sigourney B.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Enzon Pharm. Inc

Article Abstract:

The price appreciation potential of the shares of Enzon Pharmaceuticals Inc. for the years 2010-2012 is discussed. The Bridgewater, New Jersey-based company develops therapeutics for life-threatening diseases using its proprietary technologies.

Author: Romaine, Sigourney B.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
United States, Enzon Pharmaceuticals Inc., ENZN, Analyst report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, France, Securities, Company securities, SNY, Sanofi-Aventis S.A., Evaluation, Stocks, Stock prices
Similar abstracts:
  • Abstracts: Selection for growth: Korn/Ferry Int'l (KFY - 20.66). Korn/Ferry Int'l. Stock highlight: Amn Healthcare (AHS - 27.29)
  • Abstracts: Selection for growth and income: Hibbett Sports, Inc. (HIBB-28.04). Dick's Sporting
  • Abstracts: Selection for growth: Cognos, Inc. Model portfolios: recent developments. Stock highlight: Oracle Corp
  • Abstracts: Sonosite Inc. SonoSite, Inc. AngioDynamics, Inc
  • Abstracts: National City Corp. Rockwell Collins. Compass Bancshare
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.